Cannabis Law Report

MARCH 26, 2022

Jazz Pharmaceuticals is investing £75m in a plant based at Kent Science Park (KSP) in Sittingbourne, Kent. ” ‘Strategic investment’ Jazz Pharmaceuticals currently manufactures the extract, active pharmaceutical ingredients and the formulated drug products at KSP, occupying 12 buildings with more than 400 employees.

Pharmaceutical 52

Pharmaceutical Medicine Extraction Cannabinoids 52

Cannabis Law Report

MAY 29, 2021

The authorization procedure for the extraction of active ingredients and the production of cannabis extracts was published by the Ministry of Health after an explicit request from the M5S. The Ministry of Health, at our request, has made public the authorization procedure for the manufacture of cannabis extracts on its portal .

Extraction 78

Extraction Agriculture Cultivation Pharmaceutical 78

Project CBD

JULY 28, 2023

He has guided clients on license applications, facility design and build out, equipment installation and optimization, and plant oil extraction for cannabis and hemp processing facilities. At issue are potent, intoxicating cannabinoids other than cannabis-derived Δ9-THC. with unknown pharmacological and safety profiles.”

THC 212

THC Cannabinoids Hemp Research and Development 212

Cannabis Law Report

FEBRUARY 18, 2022

We are one of the first to successfully complete a commercial shipment of Colombian-manufactured high-CBD pharmaceutical product to Germany available for patients in pharmacies under prescription. In addition, this reflects our increasing know-how to comply with complex and sophisticated regulatory and quality frameworks.

Extraction 52

Extraction Pharmaceutical Patients Cannabinoids 52

Kind Meds (Cannabis Education Blog)

JANUARY 27, 2022

Lately, the cannabinoid CBN (or cannabinol) has been rising in popularity. CBN is a cannabinoid that can be synthesized out of THC. Cannabinol – more commonly known as CBN – is one of over one hundred cannabinoids found in the cannabis plant. The CBN cannabinoid begins to form when THC is oxidized. What Is CBN Extraction?

Cannabinoids 52

Cannabinoids Treatment Extraction THC 52

Cannabis Law Report

SEPTEMBER 17, 2021

Patent 16/424,351, a Cannabinoid Composition and Method of Sublingual, Buccal, and Oral Mucosa Delivery. This patent focuses on a formulation that includes a cannabinoid extract that is pharmaceutically effective by systemic delivery to the recipient’s oral mucosal lining. InBOLD Inc. announced the issuance of a U.S.

Cannabinoids 52

Cannabinoids Pharmaceutical Digestion Terpenes 52

Cannabis Law Report

JANUARY 16, 2020

(“Devonian” or the “Corporation”) (TSXv:GSD), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, announced today the signature of a lease Agreement with Hzb Pharma Canada Inc. Tweet this.

Extraction 64

Extraction Pharmaceutical Research and Development Terpenes 64

Cannabis Law Report

JANUARY 13, 2020

Hemp Synergistics, a hemp extraction laboratory producing THC-free custom CBD formulations recently announced it received $1.5 The lab has been designed to resolve the problem of inconsistent THC levels in a range of cannabinoid-based consumer products, the company told Benzinga.

Extraction 66

Extraction Hemp Environment Pharmaceutical 66

Cannabis Law Report

JUNE 1, 2022

Pharmadrug GmbH has been active worldwide for almost 40 years as a manufacturer and wholesaler of medicinal products and active pharmaceutical ingredients. Our team in Europe is excited to join forces with new colleagues from Pharmadrug GmbH, with their valuable expertise in the German pharmaceutical market.”

Pharmaceutical 52

Pharmaceutical Medicine Extraction Cannabinoids 52

CannaTech

NOVEMBER 6, 2019

In today’s blog, we are joined by Matthew Anderson, Founder/CEO Vanguard Scientific Systems, a world-leading provider of end-to-end solutions for integrated botanical extraction equipment and services. The Cannabinoid Buyer’s Needs of Tomorrow. But is this growth serving the needs of cannabinoid buyers?

Cannabinoids 74

Cannabinoids Wellness and Beauty Supply Chain Compliance 74

Cannabis Law Report

NOVEMBER 12, 2021

Ethypharm has signed an exclusive license agreement with Clever Leaves for the distribution of medical cannabis extracts in Germany, the most important European market for medical cannabis. Clever Leaves will manufacture and supply EU GMP certified medical cannabis extracts sourced from their facilities in Colombia and Portugal.

Extraction 52

Extraction Chronic Pain Pharmaceutical THC 52

Cannabis Law Report

SEPTEMBER 14, 2021

A lack of consumer trust, transparency and scientific rigor has hampered the CBD and cannabinoid industry from reaching its growth potential for far too long”. About Radicle Science. Radicle Science is a transformative healthtech B-corp offering the first ever path to natural product validation at scale.

Extraction 52

Extraction Research and Development Clinical Trials CBD 52

Veriheal

AUGUST 9, 2023

Recent research reaffirms earlier studies that claim that certain non-marijuana plants contain similar compounds found in cannabis, often called cannabinoids. This new research has increased our hopes for an alternate CBD source, which may increase the availability of CBD-based products, reduce purchase costs, and guarantee THC-free extracts.

CBD 78

CBD Cannabinoids THC Extraction 78

Cannabis Law Report

JANUARY 11, 2022

Flora’s cultivation and extraction division, Cosechemos, completed construction of a 10,500 ft 2 state-of-the-art post-harvest and extraction facility with annual capacity of 15,000 L of distillate. At this time, the team is continuing commercial CBD extraction.

Extraction 52

Extraction Wellness and Beauty Events Cultivation 52

Cannabis Law Report

NOVEMBER 17, 2021

Launch of Zylem ™ 20:1 further expands ZYUS product offerings with new cannabinoid formulation. The launch of this formulation marks an important milestone in ZYUS’ mission to elevate cannabinoids as a standard of care and leverage their transformational potential.

Cannabinoids 52

Cannabinoids Patients Research and Development Extraction 52

Cannabis Law Report

DECEMBER 1, 2021

Cannabis and Life Sciences Company Initiates Internal Study Comparing Anti-Inflammatory Properties of Candidate JUVA-019 When Combined With Cannabinoids Such as THC and CBD. who has an extensive background in pharmaceutical research and development. November 30, 2021 04:00 ET | Source: Juva Life Inc.

Cannabinoids 52

Cannabinoids Research and Development Pharmaceutical THC 52

Cannabis Law Report

SEPTEMBER 7, 2022

The acquisition by Ramm provides access to HemPoland’s distribution network, recognized premium brands, hemp oil extraction technologies, and an additional synergistic foothold into the European market following the acquisition of Sicily-based Canapar Corp. About RAMM Pharma Corp. g, Poland (60 kilometres east of Gda?sk), HemPoland S.p.a.

Hemp 59

Hemp Pharmaceutical Extraction Cannabinoids 59

Cannabis Law Report

NOVEMBER 23, 2021

SOMAÍ Pharmaceuticals Unipessoal LDA, or SOMAÍ, recently received an “innovative products” grant of 2.7 Provided by the Portugal 2020 committee, the grant will help Somaí continue its mission of developing high-quality and efficacious cannabis pharmaceuticals for the European market. million euros ($3.07

Pharmaceutical 52

Pharmaceutical Research and Development Cannabinoids Extraction 52

Canna Care Docs

OCTOBER 3, 2023

However, many of these pharmaceutical medications can just induce more unpleasant, debilitating effects on those who are ill. Depending on the type of terminal illness diagnosed by the doctor, there are numerous pharmaceutical and conventional medications provided for patients to treat the symptoms that come with a terminal illness.

Chronic Pain 105

Chronic Pain Clinical Trials Patients Cannabinoids 105

Cannabis Law Report

MAY 30, 2019

(CSE: BBT) (FSE: BBW) (OTC Pink: BHHKF) (“Benchmark”, “BBT” or the “Company”) a federally-licensed producer and distributor of medical-grade cannabis, is pleased to report that it has signed a definitive agreement with China-based Zhejiang Yatai Pharmaceutical Co.,

Pharmaceutical 40

Pharmaceutical Research and Development Extraction Cultivation 40

Cannabis Law Report

FEBRUARY 1, 2022

New softgel capsule products further expand ZYUS’ medical cannabinoid offerings and provide patients a precise method for dosing. The launch of these two new softgel products marks another important milestone in ZYUS’ mission to elevate cannabinoids as a standard of care and leverage their transformational potential.

Cannabinoids 52

Cannabinoids Patients Research and Development Media 52

Otherside Farms

MAY 1, 2023

As the cannabis industry continues to grow, the need for high-quality extraction methods becomes more important than ever. So, if you’re looking to take your cannabis business to the next level, it’s time to hop on the CO2 extraction train. What exactly is CO2 Extraction?

Extraction 52

Extraction Terpenes Oil Cannabinoids 52

CannaTech

NOVEMBER 6, 2019

In today’s blog, we are joined by Matthew Anderson, Founder/CEO Vanguard Scientific Systems, a world-leading provider of end-to-end solutions for integrated botanical extraction equipment and services. The Cannabinoid Buyer’s Needs of Tomorrow. But is this growth serving the needs of cannabinoid buyers?

Cannabinoids 40

Cannabinoids Supply Chain Compliance Compliance 40

Cannabis Law Report

JANUARY 10, 2022

Minor Cannabinoids Market Size, Share & Trends Analysis Report by Product (CBG, CBC, CBN, THCV, CBGA), by Application (Pain Management, Neurological Disorders), and Segment Forecasts, 2021-2028” report has been added to ResearchAndMarkets.com’s offering. minor cannabinoids market size is expected to reach USD 26.2

Cannabinoids 52

Cannabinoids Clinical Trials Research and Development Supply Chain 52

Cannabis Law Report

JULY 27, 2021

NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, and Biopharmaceutical Research Company (“BRC”), a specialty pharmaceutical company that holds federal licenses for importing, analyzing and manufacturing controlled substances in the U.S.,

Research and Development 98

Research and Development Pharmaceutical Sativa Extraction 98

United Patients Group

FEBRUARY 7, 2023

The effects of cannabis are caused by cannabinoids, which are chemical compounds found in the resin glands on the leaves and buds of female marijuana plants. Cannabinoids can help with inflammation and pain relief in various ways. Cannabis contains two types of cannabinoids: phytocannabinoids and endocannabinoids.

Cannabinoids 114

Cannabinoids Chronic Pain Terpenes THC 114

TheAnswerPage

MARCH 17, 2022

Other than phytocannabinoids, what active components have been extracted from cannabis plants? More than 540 active natural compounds have been extracted and characterized from the cannabis plant. The Two Sides of the Same Coin”—Medical Cannabis, Cannabinoids and Immunity: Pros and Cons Explained. Pharmaceutics 2022,14,389.

Terpenes 52

Terpenes Extraction Pharmaceutical Cannabinoids 52

TheAnswerPage

MAY 20, 2022

The oromucosal spray Sativex (nabiximols) is a cannabis extract that contains the principal cannabinoids delta-9-tetrahydrocannibinol (THC) and cannabidiol (CBD) in a 50:50 ratio, as well as specific minor cannabinoids and other non-cannabinoid components. GW Pharmaceuticals website. See the Answer.

Nerve Pain 52

Nerve Pain Epilepsy Pharmaceutical Cannabinoids 52

Cannabis Law Report

AUGUST 6, 2021

CBD, which is an abbreviation for Cannabidiol, is one of Cannabis’s primary components – one of its primary Cannabinoids. Cannabinoids are the naturally occurring compounds found in the Cannabis plant. There are over 480 different Cannabinoids in the Cannabis plant. It is non-psychoactive and has a multitude of health benefits.

CBD 105

CBD Wellness and Beauty Treatment Pharmaceutical 105

Cannabis Law Report

JANUARY 16, 2022

Malaysia’s National Pharmaceutical Regulatory Agency (NPRA) previously approved a prescription medicine derived from cannabis in 2014 to treat muscle spasms and spasticity from multiple sclerosis. Sativex was developed by GW Pharmaceuticals, a maker of cannabinoid therapeutics based in Ireland.

Research and Development 98

Research and Development Pharmaceutical Epilepsy Medicine 98

TheAnswerPage

AUGUST 19, 2021

The oromucosal spray Sativex (nabiximols) is a cannabis extract that contains the principal cannabinoids delta-9-tetrahydrocannibinol (THC) and cannabidiol (CBD) in a 50:50 ratio, as well as specific minor cannabinoids and other non-cannabinoid components. GW Pharmaceuticals website. See the Answer.

Nerve Pain 52

Nerve Pain Epilepsy Pharmaceutical Cannabinoids 52

TheAnswerPage

JUNE 14, 2021

The oromucosal spray Sativex (nabiximols) is a cannabis extract that contains the principal cannabinoids delta-9-tetrahydrocannibinol (THC) and cannabidiol (CBD) in a 50:50 ratio, as well as specific minor cannabinoids and other non-cannabinoid components. ” GW Pharmaceuticals website. See the Answer.

Nerve Pain 52

Nerve Pain Epilepsy Pharmaceutical Cannabinoids 52

Veriheal

JANUARY 25, 2022

Because of the federal legality of these products—and because the Minnesota State Legislature had previously passed a law that made non-food products containing nonintoxicating cannabinoids legal—the CBD industry in Minnesota had taken off in recent years. A theory towards a solution would be for all hemp extracts to be approved by the FDA.

Hemp 90

Hemp Business CBD Seed-To-Sale 90

FloridaMarijuana.net

AUGUST 15, 2018

The endocannabinoid system consists of cannabinoid receptors all over the body. The compounds THC (tetrahydrocannabinol) and CBD (cannabidiol) found in cannabis signal the same cannabinoid receptors as anandamide. This system enables a connection between body and mind, signaling to all other systems when something feels good or bad.

Chronic Pain 150

Chronic Pain Marijuana Patients Clinical Trials 150

Cannabis Law Report

MARCH 17, 2022

Cannabis extracts or strains are from herbal cannabis plants. It is significant to cite that cannabinoids are mainly from rural weed grains for therapeutic goals. Another phase in discovering the best-quality weed herbal commodities is purchasing the ideal mix of cannabinoids and other weed-based components. Cannabinoid Content.

CBD 52

CBD Extraction Cannabinoids Strains 52

Cannabis Law Report

APRIL 11, 2022

Rowan University in New Jersey now offers an MBA in Cannabis Commercialization with courses ranging from Cannabis Legislation, Regulations, and Policy to Advanced Chemical Analysis of Cannabinoids. The rapidly evolving cannabis industry is anticipated to become a multi-billion dollar economic driver across the USA – and beyond.

Research and Development 52

Research and Development Policy Decriminalization Pharmaceutical 52

Cannabis Law Report

JUNE 28, 2021

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. Zambon is a multinational pharmaceutical company that focuses on innovation and development with the aim to improve patients’ lives. The market for medical cannabis in Germany.

Access 105

Access Research and Development Pharmaceutical Therapy 105